Presentation TCT 2012 When Should the MitraClip Be Considered for Front-Line Therapy of Degenerative MR? Presenter: Michael Rinaldi October 23, 2012
Presentation TCT 2012 TCT-9. Morphological Assessment of Renal Arteries After Radiofrequency Catheter-based Sympathetic Denervation in a Porcine Model Presenter: Michael Joner October 23, 2012
Presentation TCT 2012 TCT-38. Two-year Clinical Data of Cohort 1 and Multi-modality Imaging Results Up to 1-year Follow-up of the BIOSOLVE-I Study with the Paclitaxel-eluting Bioabsorbable... Presenter: Michael Haude October 23, 2012
Presentation TCT 2012 TCT-55. Major Adverse Cardiac Events Associated with Discontinuation of Clopidogrel Treatment Within the First Year After Coronary Stent Implantation in Western Denmark Presenter: Michael Maeng October 23, 2012
Presentation TCT 2012 REMEDEE Combo (OrbusNeich) Program Update Presenter: Michael Haude October 23, 2012
Presentation TCT 2012 Update on CCSVI: Are We Any Closer to Understanding This Entity and Its Therapy? Presenter: Michael Dake October 22, 2012
Presentation TCT 2012 The Importance of Central Venous Occlusion, Techniques for Intervention, and Long-term Expectation of Outcomes Presenter: Michael Dake October 22, 2012
Presentation TCT 2012 The Art and Science of Risk Stratification in Aortic Stenosis: Updates on Risk Scores, Futility, and Other Imponderables Presenter: Michael Mack October 22, 2012
Presentation TCT 2012 What Is Optimal Medical Management for Carotid Disease, and What Residual Risk Remains Without Revascularization? Presenter: Michael Jaff October 22, 2012
Presentation TCT 2012 Role of Renal Revascularization in 2012 and Predictions for the Future Presenter: Michael Jaff October 22, 2012
Presentation 3-Year Clinical Outcomes in SORT OUT III Comparing Zotarolimus- and Sirolimus-Eluting Coronary Stents Presenter: Michael Maeng August 21, 2012
Presentation TVT 2012 Why and How Often Mitral Surgery Fails—or Is Suboptimal—After (Early and Late) MitraClip Failure Presenter: Michael Mack June 05, 2012
Presentation TVT 2012 Frequency and Reasons for Mitral Valve Replacement Rather Than Repair: Is It the Patients or the Surgeons? Presenter: Michael Mack June 05, 2012
Presentation TVT 2012 Surgery for Functional MR: Guidelines, Approaches, and Outcomes Presenter: Michael Mack June 04, 2012
Presentation EuroPCR 2012 Twelve-month clinical and angiographic results of the multicenter first-in-man BIOSOLVE-I study with the Paclitaxel-Eluting Bioabsorbable Magnesium Scaffold Presenter: 12690|Michael Haude May 18, 2012
Presentation MOBILITY: Modern Endovascular Management of Patients with Iliac Artery Disease Presenter: Michael R. Jaff May 11, 2012
Presentation Fellows 2012 Oral Antithrombin and Xa Inhibitors for ACS and PCI Presenter: Michael Ezekowitz April 22, 2012
Presentation PCI Outcomes 2012 PCI in NSTEMI and STEMI: Essentials of Pharmacology Presenter: C. Michael Gibson March 23, 2012
Presentation TCT 2012 Percutaneous Abdominal Aortic Aneurysm Repair: Methods and Initial Outcomes from the First Prospective, Multicenter Trial Presenter: Zvonimir Krajcer, Peter R. Nelson, Christian Bianchi, Vikram Rao, Mark D. Morasch, Michael Bacharach January 03, 2012